![The LLS PedAL Master Trial: A Clinical Trial for Acute Myeloid Leukemia Pediatric Patients | Leukemia and Lymphoma Society The LLS PedAL Master Trial: A Clinical Trial for Acute Myeloid Leukemia Pediatric Patients | Leukemia and Lymphoma Society](https://www.lls.org/sites/default/files/styles/product_page_image/public/2021-12/FF20_LLS_PedAL_OnePager_12_21.jpg?itok=hVaKsSA9)
The LLS PedAL Master Trial: A Clinical Trial for Acute Myeloid Leukemia Pediatric Patients | Leukemia and Lymphoma Society
![New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-020-00376-1/MediaObjects/41408_2020_376_Fig1_HTML.png)
New directions for emerging therapies in acute myeloid leukemia: the next chapter | Blood Cancer Journal
![Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial | Nature Medicine Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-020-1089-8/MediaObjects/41591_2020_1089_Fig1_HTML.png)
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial | Nature Medicine
PLOS ONE: High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials
![FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death | Fierce Biotech FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death | Fierce Biotech](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1637761803/5204602349_c87b204860_b.jpg/5204602349_c87b204860_b.jpg?VersionId=OVMY82lkX0TGsUk_N5mQdxx6u85oN7ET)
FDA halts phase 1b Kura Oncology trial in acute myeloid leukemia following patient death | Fierce Biotech
![AML Clinical Trials Guide - AML Resource Guides - AML Precision Therapy - Oncology - Clinical Care Options AML Clinical Trials Guide - AML Resource Guides - AML Precision Therapy - Oncology - Clinical Care Options](https://www.clinicaloptions.com/-/media/oncology/programs/aml-precision-therapy/cco_ash_aml_2018_clinical-trials_thumbnail.png?rev=fad9fec88b0945518abf6f7f1e8bdf36&h=166&w=295&la=en&hash=58826FD4712B2448DFD8A3C074569F1BA67531C4)
AML Clinical Trials Guide - AML Resource Guides - AML Precision Therapy - Oncology - Clinical Care Options
![Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy | Signal Transduction and Targeted Therapy Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00361-x/MediaObjects/41392_2020_361_Fig1_HTML.png)